I Holland Launched Innovative New Product Developments at ACHEMA
I Holland has launched two innovative new products at ACHEMA, Frankfurt.
Showcasing for the first time was XDF (eXtended Dwell Flat) a novel patented elliptical head form which has been designed to increase dwell time on an existing press without the need for expensive modifications.
Designed to run on standard cams, it can give users higher press speeds with challenging products and formulations. XDF also enhances tablet compaction and cohesion and can increase dwell time by up to 50% over a standard punch head allowing more dwell than a D-type punch on a B-type tool. This increase helps to solve compression problems without upsizing punches or investing in a new press.
Steve Osborn said: I Holland's XDF has been designed to give manufacturers the tool to produce superior quality tablets. It was created to be run on an existing press on standard cams. This is an important benefit of XDF as it saves on capital outlay, whilst at the same time improving and increasing productivity with enhanced tablet production, resulting in a quality tablet.
Exhibiting alongside I Hollands XDF is the new Tool Management System IH-TMS which allows proactive monitoring of tool rotations and tooling inventory and maintenance.
The stand-alone system allows tablet manufacturers to keep a record of tablet quantities by number of tablets, work order or batch information to ensure production is run efficiently. In addition it has the capability to archive tablet and tool images and drawings.
IH-TMS software is the pinnacle in tablet tool management as it can maintain efficient, well-organised and in-depth monitoring of tablet production. It also incorporates an alarm to alert users of any problems including over compression, tooling replacements or if maintenance is required. It has been created for manufacturers to have a complete audit trail on production, which is obviously important in tablet manufacture, adds Andy Dumelow, I Holland's PharmaCare Product Manager.
Available in several languages and with an embedded copy of the Eurostandard Educational Suite, I Hollands IH-TMS Tool Management System, together with the innovative XDF were well received at Achema.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance